Answer:
A. The proposed new project would have more stand-alone risk than the firm's typical project.
Explanation:
Answer:
Pharma One
The statement that indicates that KleenKare is a cash cow according to the the Boston Consulting Group (BCG) matrix is:
2. The demand for analgesic drugs in the Syrian market is expected to maintain a low-growth, high-share status.
Explanation:
A cash cow depicts the BCG matrix quadrant where there are higher returns, high market share in a low-growth market. The cash cow requires little investment to generate high returns. It also provides the cash for financing the other quadrants (dogs, stars, and question marks). Basically, the BCG matrix, also known as the Growth/Share Matrix, depicts the products' growth opportunities.
Answer:
$1.25
Explanation:
dividend growth:
year growth rate dividends
1 24% Div₁ = 1.24Div₀
2 24% Div₂ = 1.24²Div₀ = 1.5376Div₀
3 24% Div₃ = 1.24³Div₀ = 1.906624Div₀
4 14% Div₄ = 1.906624Div₀ x 1.14 = 2.17355136Div₀
indefinite 8% Div₅ = 2.17355136Div₀ x 1.08 = 2.347435Div₀
required rate of return = 10%
current stock price = $86
stock price for terminal growth rate = Div₅ / (10% - 8%) = Div₅ / 2% = 117.3717734Div₀
current stock price = $86 = 1.24Div₀/1.1 + 1.5376Div₀/1.1² + 1.906624Div₀/1.1³ + 2.17355136Div₀/1.1⁴ + 117.3717734Div₀/1.1⁴ = 1.12727Div₀ + 1.27074Div₀ + 1.43247Div₀ + 1.48456Div₀ + 80.1665Div₀ = 85.48154Div₀
$86 = 85.48154Div₀
Div₀ = $86 / 85.48154 = $1.006065
Div₁ = 1.24 x $1.006065 = $1.2475 ≈ $1.25
Answer:
The correct answer is 2. provides the supporting reasons before the primary message.
Explanation:
Answer:
$140,420
Explanation:
The demand function is q = -720p + 20,500.
The price is $17
q = -720 ($17) + 20500 = 8260
The quantity sold is 8260
Revenue = price × quantity sold
= $17 × 8260 = $140,420
